Mint Tower Capital Management’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Mint Tower Capital Management’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	25,000	–	–	﹤0.01%	342
2026 Q1	$1K	Hold	25,000	–	–	﹤0.01%	336
2025 Q4	$1K	Hold	25,000	–	–	﹤0.01%	264
2025 Q3	$1K	Hold	25,000	–	–	﹤0.01%	201
2025 Q2	$1K	Hold	25,000	–	–	﹤0.01%	159
2025 Q1	$2K	Hold	25,000	–	–	﹤0.01%	138
2024 Q4	$1K	Hold	25,000	–	–	﹤0.01%	142
2024 Q3	$1K	Buy	+25,000	New	+$1.45K	﹤0.01%	146

Other funds holding SLXNW

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mint Tower Capital Management's SLXNW Position: Q2 2026 in Review

Mint Tower Capital Management held its Silexion Therapeutics Warrant (SLXNW) position steady in Q2 2026 at 25,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Mint Tower Capital Management first reported a position in SLXNW in Q3 2024 and has held it in 8 quarters since. The position peaked at $2K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q2 2026.

Mint Tower Capital Management held 25,000 shares of Silexion Therapeutics Warrant worth $1K as of Q2 2026.
Mint Tower Capital Management left its Silexion Therapeutics Warrant share count unchanged in Q2 2026.
Silexion Therapeutics Warrant made up ﹤0.01% of Mint Tower Capital Management's portfolio in Q2 2026, its #342 holding.
Mint Tower Capital Management first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 8 quarters since.
Mint Tower Capital Management's Silexion Therapeutics Warrant position peaked at $2K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q2 2026.

Based on Mint Tower Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.